Obstructive Sleep Apnea and Cardiovascular Disease - A New Target for Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|24|3496-3504

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.24, 2015-01, pp. : 3496-3504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Treatment of Obstructive Sleep Apnea

By  

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1418-1425

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Morbidity and Mortality in Obstructive Sleep Apnea

By  

Current Pharmaceutical Design, Vol. 14, Iss. 32, 2008-11 ,pp. : 3466-3473

Bentham Science Publishers

Access to resources Recommend Favorite

Obstructive Sleep Apnea: What Does the Cardiovascular Physician Need to Know?

By Nancy A. Collop  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 2, 2005-01 ,pp. : 71-81

Adis International

Access to resources Recommend Favorite

Importance of laboratory parameters in patients with obstructive sleep apnea and their relationship with cardiovascular diseases

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacotherapy of obstructive sleep apnea

By Lin Chia Mo   Huang Yu Shu   Guilleminault Christian  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 841-857

Informa Healthcare

Access to resources Recommend Favorite